Harmony Biosciences Management
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Harmony Biosciences Management sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Harmony Biosciences Management: 10 sponsored US clinical trials, 4 recruiting.
Harmony Biosciences Management sponsors 10 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prader-Willi Syndrome, with 2 trials.
Top-decile sponsor footprint
Harmony Biosciences Management ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
NCT07675135
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
NCT07500090
A Study of Pitolisant in Patients With Prader-Willi Syndrome
NCT06366464
WAKIX® (Pitolisant) Pregnancy Registry
NCT05536011
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
NCT04257929
A Study of HBS-201 (Pitolisant Delayed-release)
NCT07051252
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
NCT05458128
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
NCT05156047
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
NCT04886518
Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
NCT05149898
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 5 |
Therapeutic Areas
What is open in the Harmony Biosciences Management pipeline
4 recruiting of 10 indexed (40% open); 5 completed (50%).
Phase mix: 5 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Prader-Willi Syndrome (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Harmony Biosciences Management: open-pipeline peers nationwide
Peers matched on 10 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Harmony Biosciences Management sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Harmony Biosciences Management page
10 registered trials is a research-attention snapshot, not an endorsement of Harmony Biosciences Management or any single study.
- 4 of Harmony Biosciences Management's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prader-Willi Syndrome is the condition Harmony Biosciences Management studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prader-Willi Syndrome trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Harmony Biosciences Management pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.